SYNOVUS FINANCIAL CORP - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 238 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2022. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.

Quarter-by-quarter ownership
SYNOVUS FINANCIAL CORP ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2023$2,018,744
-21.1%
40,198
-0.7%
0.02%
-17.9%
Q2 2023$2,558,396
+31.9%
40,481
-6.1%
0.03%
+27.3%
Q1 2023$1,939,654
-7.4%
43,113
-9.8%
0.02%
-8.3%
Q4 2022$2,095,126
-7.4%
47,823
+39.2%
0.02%
-14.3%
Q3 2022$2,262,000
+51.8%
34,357
+16.3%
0.03%
+64.7%
Q2 2022$1,490,000
-12.5%
29,549
+10.6%
0.02%
-5.6%
Q1 2022$1,703,000
-25.7%
26,723
+24.8%
0.02%
-21.7%
Q4 2021$2,293,000
+5.5%
21,405
+1.0%
0.02%0.0%
Q3 2021$2,174,000
+63.7%
21,186
+40.2%
0.02%
+76.9%
Q2 2021$1,328,000
-4.6%
15,112
+5.5%
0.01%
-18.8%
Q1 2021$1,392,000
+27740.0%
14,322
+22633.3%
0.02%
Q2 2020$5,000
+25.0%
630.0%0.00%
Q1 2020$4,000
-20.0%
630.0%0.00%
Q4 2019$5,0000.0%630.0%0.00%
Q3 2019$5,000
-16.7%
630.0%0.00%
Q2 2019$6,000
+20.0%
630.0%0.00%
Q1 2019$5,000
+66.7%
630.0%0.00%
Q4 2018$3,000
-40.0%
630.0%0.00%
Q3 2018$5,000630.00%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q2 2022
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 716,539$36,192,00012.35%
CADIAN CAPITAL MANAGEMENT, LP 2,020,629$102,062,0006.89%
Casdin Capital, LLC 1,150,000$58,087,0004.91%
DAFNA Capital Management LLC 261,280$13,197,0003.60%
Nextech Invest Ltd. 188,228$9,507,0003.21%
Eagle Health Investments LP 170,551$8,615,0002.01%
Boxer Capital, LLC 507,374$25,627,0001.62%
Rock Springs Capital Management LP 979,174$49,458,0001.44%
EFG Asset Management (North America) Corp. 130,454$6,589,0001.39%
Integral Health Asset Management, LLC 130,000$6,566,0001.35%
View complete list of BLUEPRINT MEDICINES CORP shareholders